STERIS plc News
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
see moreSTERIS plc Market News
5d
Steris (STE) Oversold Signal and Obsolescence Alert!!
- Steris (STE) saw a sharp technical oversell (RSI ~24) amid broader market pressures, while issuing a service obsolescence notice for select OR integration monitors. These concrete developments — a pronounced technical indicator, a product lifecycle transition, and ongoing restructuring — create near-term operational and valuation implications for investors.
26d
Steris Drops; Danaher-Masimo Deal Rattles MedTech!
Steris (STE) underperformed this week amid elevated trading volume and sector activity. While Steris posted no major company-specific announcements, investors reacted to weaker relative performance versus peers and a flurry of MedTech M&A and earnings updates — notably Danaher's agreed acquisition of Masimo and Medtronic's mixed quarter — which are reshaping investor expectations across the S&P 500 healthcare equipment group.
10 Feb at 14:42
Steris (STE) Q3 Beat, Margins Pressure, Stock Drop
Steris reported fiscal Q3 results with a revenue beat and strong cash flow, yet shrinking gross margins and heavy after‑hours selling drove an intraday stock decline. Key drivers include robust AST capital equipment sales, rising cost of revenues, and elevated trading volume—factors investors should monitor in upcoming guidance.